Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach
Lewis D. Turner, Alexander L. Nielsen, Lucy Lin, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 6, pp. 960-969
Open Access | Times Cited: 12

Showing 12 citing articles:

Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update
Marco Pirazzini, Cesare Montecucco, Ornella Rossetto
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1521-1539
Open Access | Times Cited: 50
Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication Studies
Ealin N. Patel, Lucy Lin, Hyeri Park, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 11, pp. 3744-3750
Closed Access | Times Cited: 1
Yeast Display Enables Identification of Covalent Single-Domain Antibodies against Botulinum Neurotoxin Light Chain A
Rafael Alcala‐Torano, Mariha Islam, Jaclyn Cika, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 12, pp. 3435-3449
Open Access | Times Cited: 10
Transformation of a Metal Chelate into a “Catch and Anchor” Inhibitor of Botulinum A Protease
Lucy Lin, Ealin N. Patel, Alexander L. Nielsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4303-4303
Open Access | Times Cited: 3
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine
Kaitlin R. Hulce, Priyadarshini Jaishankar, Gregory M. Lee, et al.
Cell chemical biology (2022) Vol. 29, Iss. 5, pp. 785-798.e19
Open Access | Times Cited: 6
Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A
Yongpeng Wei, Guangyao Li, Zhuo Wang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 2, pp. 213-222
Closed Access
Emerging opportunities for intact and native protein analysis using chemical proteomics
Alexis N. Edwards, Ku‐Lung Hsu
Analytica Chimica Acta (2024) Vol. 1338, pp. 343551-343551
Closed Access
Identification of Slow-Binding Inhibitors of the BoNT/A Protease
Ealin N. Patel, Lewis D. Turner, Mark S. Hixon, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 4, pp. 742-747
Open Access | Times Cited: 3
Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease
Lewis D. Turner, Alexander L. Nielsen, Lucy Lin, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 8, pp. 1318-1324
Open Access | Times Cited: 4
Synthesis and activity evaluation of selenazole-coupled CPI-1 irreversible bifunctional inhibitors for botulinum toxin A light chain
Jia Liu, Shujing Xu, Chao Huang, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 73, pp. 128913-128913
Closed Access | Times Cited: 2
Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease
Lewis D. Turner, Alexander L. Nielsen, Lucy Lin, et al.
(2021)
Open Access
Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease
Lewis D. Turner, Alexander L. Nielsen, Lucy Lin, et al.
(2021)
Open Access
Page 1

Scroll to top